Athens, 13/01/2026
The Hellenic Digital Health Cluster (HDHC) and the Association of Medical & Biotechnological Products and Businesses (SEIV) sent a joint letter to the Ministry of Health and the National Organization for the Provision of Health Services (EOPYY), regarding the urgent need to issue a Joint Ministerial Decision (JMD) for the reimbursement of tele-monitoring services for medical devices and digital health applications.
The letter focuses on the pending implementation of Ministerial Decision 7686/2025 (Government Gazette B' 1083/10-03-2025), which defines the general framework for the operation of telemedicine, without, however, the envisaged Joint Ministerial Decision for the compensation of the relevant medical procedures by EOPYY having been issued, as provided for by Law 5184/2025.
Three distinct categories of technologies
The letter points out that the JMD must cover at least three distinct categories of medical devices:
- Implantable cardiac devices, such as pacemakers and defibrillators, require systematic monitoring of thousands of patients annually. Telemonitoring can drastically reduce the movement of patients from island and remote areas to large urban centers.
- Non-implantable tele-monitoring devices, such as continuous glucose monitoring (CGM) systems and Remote Patient Monitoring (RPM) devices , with mature scientific documentation and proven clinical benefit.
- SaMD (Software as a Medical Device) applications and software , which constitute an emerging but critical field for digital health, with a need for rigorous evaluation of documentation and clinical effectiveness.
Financial documentation and discrete budget
HDHC and SEIB emphasize the need to prepare a documented economic study (HTA & Budget Impact) , so that the inclusion of new compensation measures is based on real cost-benefit data. At the same time, it is proposed to provide a separate budget within EOPYY, in order to avoid burdening other expenditure lines and creating new clawback mechanisms .
Proposal to establish a Working Group
In this context, it is proposed to create a small joint Working Group with the participation of the Ministry of Health, EOPYY, HDHC, SEIB, scientific societies and the Greek Patients' Association. The aim of the group will be the precise definition of medical procedures, the prioritization of technologies, the patient inclusion criteria, the interoperability requirements, as well as the support of the JMD issuance process.
Benefits for patients, healthcare system and innovation
The issuance of the JMD is expected to contribute substantially to:
- improving patients' access to health services,
- reducing travel and expenses,
- to decongest hospitals,
- and strengthening Primary Health Care.
At the same time, it will create a stable and predictable framework for the Greek ecosystem of digital health and medical devices, encouraging innovation, investment and the international extroversion of Greek businesses.
The joint letter is signed by Dimitrios Katehakis, Director of HDHC , and Thanasis Akalestos, Director of SEIV.